Archive: 31/05/2019
Pre-surgical immunotherapy shows promise in trial for patients with early stage lung cancer
For patients with operable non-small cell lung cancer (NSCLC), pre-surgical "neoadjuvant" treatment with an immune checkpoint inhibitor was well tolerated and, in many cases, caused significant tumor cell death in a large, ...
May 31, 2019